Dr Samantha Walker, Director of Research and Innovation at Asthma + Lung UK, the leading lung charity, discusses the socioeconomic costs of lung conditions and the need for great lung health research.
The COcoa supplement and multivitamin outcomes study (COSMOS) revealed promising results in the fight against cognitive decline and Alzheimer's disease.
Secarna Pharmaceuticals, the next-generation antisense drug discovery and development company, is developing novel approaches to successfully target Neuropilin 1 (NRP1), a promising target for the treatment of cancer.
Scientists from the University of Liverpool and Liverpool School of Tropical Medicine (LSTM) have taken a huge step forward in combating the global threat of malaria.
Avinav Nigam, Founder of Tern Group, discusses the NHS staffing crisis and why, in addressing this challenge, policymakers must consider the interplay between migration policies, societal challenges, and the healthcare sector’s needs.
With the number of hip fractures projected to double by 2050, Dr Philippe Halbout, CEO of the International Osteoporosis Foundation, calls for timely action, including post-fracture care to prevent costly and life-threatening secondary fractures.
Dr Tracey Pollard from RNID, the charity which supports the 12 million people in the UK who are deaf, have hearing loss or tinnitus, talks us through the causes and impact of hearing loss and how RNID is working to improve research and related treatments in this field.
The Health Tech Alliance explains the importance of digital and technological innovations, particularly virtual wards, in supporting NHS healthcare providers.
A new policy brief from the European Observatory created with and for the Swedish Presidency of the Council of the EU details concrete steps for urgent action on AMR.
A groundbreaking global study has, determined the ideal step count that maximizes benefits for the majority of individuals, while also revealing the added advantages of walking at a certain pace.
As global air pollution levels increase, so has the toll it has taken on human health, as new data from the Air Quality Life Index (AQLI) reveals. However, this toll is not felt equally across the globe; why?
Rhett Reichard, PhD and Keri C. Smith, PhD from Saba University School of Medicine, says that while multiple sclerosis is a debilitating disease, new treatments offer hope.
